Empowering W.H.O. as a Global Authority and Centralized Pool of Resources for Speedy Development of Orphan drugs at Reduced Cost
Journal Title: Journal of Pharmaceutical Sciences and Research - Year 2010, Vol 2, Issue 12
Abstract
Orphan drugs are the drugs that are used to treat a rare disease affecting a very small segment of population. Since new drug development and approval process requires an expenditure of about US$ 1 billion and a time of 10-12 years, therefore, no company is willing to come forward for development of an orphan drug because of low returns. As a consequence rare diseases are becoming global menace. Incentives offered by developed countries i.e. U.S.A., EU & Japan are inadequate. Even no single developed country can afford development of large number of orphan drugs owing to increased cost of drug development amalgamated with low financial return for thousands of rare diseases. There is a strong need for adopting unified approach by creating a centralized pool of resources under the auspices of World Health Organization (W.H.O.) for speedy development of orphan drugs. Developed countries like U.S.A, EU and developing countries with emerging economies such as China and India can play vital role in such a unified approach. This will naturally avoid unnecessary duplication of efforts, resources and facilitate speedy development of orphan drugs at a reduced cost for benefit of all concerned at a global level. People residing in both the developing counties as well as developed world will be equally benefited by this approach. Approval by W.H.O. alone should suffice the purpose for introduction of new orphan drugs all over the world as a special case in order to avoid unnecessary delays and to save precious lives.
Authors and Affiliations
Vipul K. Gupta , Promila Gupta , Rajendra K. Songara
Keywords
Related Articles
- EP ID EP150116
- DOI -
- Views 88
- Downloads 0
Pharmacognostical standardization of leaves of Ixora coccinea, linn.
[i]Ixora coccinea LInn.[/i] is traditionally found to be useful for many ailments like hepatoprotective, chemoprotective, antimicrobial, antioxidant, antinociceptive and anti-inflammatory activities. The present study hi...
[b][/b]Evaluation of antimicrobial activity and phytochemical screening of Gelidium acerosa
Seaweeds has become a recognized potential natural product in pharmaceutical industries. The Gelidium acerosa contain large amount of valuable phytochemicals like sapononins, flavinoids and alkaloids etc...
Novel Inclusion Complexs Of Oseltamivir Phosphate-With ß Cyclodextrin: Physico-Chemical Characterization.
The purpose of this research was to mask the intensely bitter taste of Oseltamivir Phosphate (OP) Taste masking was done using beta-cyclodextrin (CD). Prepared complexes were characterized using several techniques, nam...
Hemlock poisoning due to plant misidentification
A case report (two patients) of accidental intoxication occurred in Northern Italy. Conium maculatum L. (poison hemlock) leaves were confused with and collected as Foeniculum vulgare Mill. (sweet fennel). C. m...
Expression of Cholera toxin B subunit in Banana callus culture
Plants present a low cost agriculturally based effective production system for high value therapeutic system. The process of developing an edible vaccine begins by selecting a suitable vaccine gene of a pathogen and sele...